Cardiology
News
FDA advises stopping SGLT2 inhibitor treatment prior to surgery
The changes affect canagliflozin, dapagliflozin, empagliflozin, and ertugliflozin, and were made because surgery may put patients taking SGLT2...
News
PARAGON-HF: Optimal systolic pressure in HFpEF is 120-129 mm Hg
News
ICH survival lags in the community setting
LOS ANGELES – An observed 6-month mortality of 64% in a Dutch study contrasts with better survival in interventional trials.
News
Trump to governors: Don’t wait for feds on medical supplies
President Trump outlined new guidance for Americans to avoid gatherings of more than 10 people.
News
ESC says continue hypertension meds despite COVID-19 concern
European Society of Cardiology cites lack of data for theoretical link between ACE inhibitors and ARBs with COVID-19 infection risk.
News
Risk factors for death from COVID-19 identified in Wuhan patients
The odds of dying in the hospital increased with age, higher SOFA score, and D-dimer level exceeding 1 mcg/L.
News
AUGUSTUS: Apixaban surpassed warfarin despite prior stroke or thromboembolism
LOS ANGELES – Secondary AUGUSTUS analysis showed ACS/PCI patients with AFib plus prior stroke, TIA, or thromboembolism did better on apixaban.
News
AFib patients do best on a DOAC started 7-10 days post stroke
LOS ANGELES – Observational data hints at the best time to start oral anticoagulation in AFib patients after a cardioembolic stroke.
News
MACE benefits with dapagliflozin improve with disease duration
Findings suggest treatment with the SGLT-2 inhibitor should be initiated early in some high-risk patients.
News
AI algorithm finds diagnostic AFib signatures in normal ECGs
NATIONAL HARBOR, MD. –